These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20415569)

  • 1. Interventions for HIV and hepatitis C virus infections in recreational drug users.
    Khalsa JH; Elkashef A
    Clin Infect Dis; 2010 Jun; 50(11):1505-11. PubMed ID: 20415569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.
    Khalsa JH; Vocci F
    J Addict Dis; 2008; 27(2):1-10. PubMed ID: 18681186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
    Khalsa JH; Kresina T; Sherman K; Vocci F
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients.
    McGovern B; Fiore J; Wurcel A; Taglienti P; Bradley M; Galvin S; Libone G; Ramsey J; Molinaro-Gudas V; Drewniak S; Amick C; Andalkar A; Scheft H; Bica I
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S56-62. PubMed ID: 16265615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus.
    Cournos F; McKinnon K; Sullivan G
    J Clin Psychiatry; 2005; 66 Suppl 6():27-33. PubMed ID: 16107181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
    J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus and hepatitis C virus co-infection.
    Vlahakis SR
    J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
    Wang YC; Xu SH; Li XH; Song AJ; Jia XR; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
    Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C infection among drug users in northern Thailand.
    Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
    Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
    Kretzschmar M; Wiessing L
    AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.